Marzia Del Re
0000-0001-7343-6161
Universita' di Pisa
100 papers found
Refreshing results…
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients
Comparative evaluation of molecular methods for the quantitative measure of torquetenovirus viremia, the new surrogate marker of immune competence
The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan
Drug-drug interactions in breast cancer patients treated with CDK4/6 inhibitors
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients
Recommendations for using molecular assays on liquid biopsy: the first document provided by intersociety Group AIOM, SIF, SIAPEC-IAP, SIBioC
The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer
Reccomendations for using of molecular assays on liquid biopsy: The first document provided by intersociety Group AIOM, SIF, SIAPEC-IAP, SIBioC.,Raccomandazioni per l’esecuzione di indagini molecolari su biopsia liquida in oncologia
Radiomics and liquid biopsy in oncology: the holons of systems medicine
The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response
Predicting fluoropyrimidine-related toxicity: turning wish to will, the PAMM-EORTC position
EGFR-TKIs in non-small-cell lung cancer: focus on clinical pharmacology and mechanisms of resistance
Pharmacogenetics of androgen signaling in prostate cancer: Focus on castration resistance and predictive biomarkers of response to treatment
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC
Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro
Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment
Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells
Clinical pharmacology of intravitreal anti-VEGF drugs
Pharmacokinetic Markers of 5-Fluorouracil Toxicity in Clinical Trials and Real World
Missing publications? Search for publications with a matching author name.